CARLSBAD, Calif.--(BUSINESS WIRE)--Nov. 7, 2017--
GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of
automated, multiplex molecular diagnostic testing systems, today
announced that President and Chief Executive Officer, Hany Massarany,
will present at the Canaccord Genuity Medical Technologies & Diagnostics
Forum in New York, NY.
Mr. Massarany will participate in an analyst-led fireside chat on
Thursday, November 9, at 3:00 PM Eastern Time. Interested parties may
access a live and archived webcast of the event at ir.genmarkdx.com.
About GenMark Diagnostics
GenMark Diagnostics (NASDAQ:GNMK) is a leading provider of multiplex
molecular diagnostic solutions designed to enhance patient care, improve
key quality metrics, and reduce the total cost-of-care. Utilizing
GenMark's proprietary eSensor® detection technology, GenMark's eSensor
XT-8® and ePlex® systems are designed to support a broad range of
molecular diagnostic tests with compact, easy-to-use workstations and
self-contained, disposable test cartridges. GenMark’s ePlex: The True
Sample-to-Answer Solution™ is designed to optimize laboratory
efficiency and address a broad range of infectious disease testing
needs, including respiratory, bloodstream, and gastrointestinal
infections. For more information, visit www.genmarkdx.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20171107006919/en/
Source: GenMark Diagnostics, Inc.
Investor Relations Contact
GenMark Diagnostics, Inc.
Pieper Lewis or Leigh Salvo